Literature DB >> 34112698

Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History.

Livius Penter1,2,3,4, Satyen H Gohil1,2,3,5,6, Caleb Lareau2,7,8, Leif S Ludwig2,7,9,10, Erin M Parry1,2,3, Teddy Huang1,11, Shuqiang Li1,11, Wandi Zhang1, Dimitri Livitz2, Ignaty Leshchiner2, Laxmi Parida12, Gad Getz2,3,13,14, Laura Z Rassenti15, Thomas J Kipps15, Jennifer R Brown1,3,16, Matthew S Davids1,3,16, Donna S Neuberg17, Kenneth J Livak1,11, Vijay G Sankaran2,7,18, Catherine J Wu1,2,3,16.   

Abstract

While cancers evolve during disease progression and in response to therapy, temporal dynamics remain difficult to study in humans due to the lack of consistent barcodes marking individual clones in vivo. We employ mitochondrial single-cell assay for transposase-accessible chromatin with sequencing to profile 163,279 cells from 9 patients with chronic lymphocytic leukemia (CLL) collected across disease course and utilize mitochondrial DNA (mtDNA) mutations as natural genetic markers of cancer clones. We observe stable propagation of mtDNA mutations over years in the absence of strong selective pressure, indicating clonal persistence, but dramatic changes following tight bottlenecks, including disease transformation and relapse posttherapy, paralleled by acquisition of copy-number variants and changes in chromatin accessibility and gene expression. Furthermore, we link CLL subclones to distinct chromatin states, providing insight into nongenetic sources of relapse. mtDNA mutations thus mirror disease history and provide naturally occurring genetic barcodes to enable patient-specific study of cancer subclonal dynamics. SIGNIFICANCE: Single-cell multi-omic profiling of CLL reveals the utility of somatic mtDNA mutations as in vivo barcodes, which mark subclones that can evolve over time along with changes in accessible chromatin and gene expression profiles to capture dynamics of disease evolution. See related commentary by Hilton and Scott, p. 2965. This article is highlighted in the In This Issue feature, p. 2945. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34112698      PMCID: PMC8660953          DOI: 10.1158/2159-8290.CD-21-0276

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  48 in total

1.  The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.

Authors:  E Satterwhite; T Sonoki; T G Willis; L Harder; R Nowak; E L Arriola; H Liu; H P Price; S Gesk; D Steinemann; B Schlegelberger; D G Oscier; R Siebert; P W Tucker; M J Dyer
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

2.  Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug Resistance.

Authors:  Shella Saint Fleur-Lominy; Nikki A Evensen; Teena Bhatla; Gunjan Sethia; Sonali Narang; Jun H Choi; Xiaotu Ma; Jun J Yang; Stephen Kelly; Elizabeth Raetz; Richard C Harvey; Cheryl Willman; Mignon L Loh; Stephen P Hunger; Patrick A Brown; Kylie M Getz; Cem Meydan; Christopher E Mason; Aristotelis Tsirigos; William L Carroll
Journal:  Cancer Res       Date:  2020-10-16       Impact factor: 12.701

3.  Growth dynamics in naturally progressing chronic lymphocytic leukaemia.

Authors:  Michaela Gruber; Ivana Bozic; Ignaty Leshchiner; Dimitri Livitz; Kristen Stevenson; Laura Rassenti; Daniel Rosebrock; Amaro Taylor-Weiner; Oriol Olive; Reaha Goyetche; Stacey M Fernandes; Jing Sun; Chip Stewart; Alicia Wong; Carrie Cibulskis; Wandi Zhang; Johannes G Reiter; Jeffrey M Gerold; John G Gribben; Kanti R Rai; Michael J Keating; Jennifer R Brown; Donna Neuberg; Thomas J Kipps; Martin A Nowak; Gad Getz; Catherine J Wu
Journal:  Nature       Date:  2019-05-29       Impact factor: 49.962

4.  Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease.

Authors:  Yohei Kirino; Yu-Ichi Goto; Yolanda Campos; Joaquin Arenas; Tsutomu Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

5.  Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B.

Authors:  Carolina R Batista; Michelle Lim; Anne-Sophie Laramée; Faisal Abu-Sardanah; Li S Xu; Rajon Hossain; Gillian I Bell; David A Hess; Rodney P DeKoter
Journal:  Blood Adv       Date:  2018-11-13

6.  Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications.

Authors:  J S Carew; Y Zhou; M Albitar; J D Carew; M J Keating; Peng Huang
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

7.  Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.

Authors:  Alexander N Gorelick; Minsoo Kim; Walid K Chatila; Konnor La; A Ari Hakimi; Michael F Berger; Barry S Taylor; Payam A Gammage; Ed Reznik
Journal:  Nat Metab       Date:  2021-04-08

8.  Somatic mutations and cell identity linked by Genotyping of Transcriptomes.

Authors:  Anna S Nam; Kyu-Tae Kim; Ronan Chaligne; Franco Izzo; Chelston Ang; Justin Taylor; Robert M Myers; Ghaith Abu-Zeinah; Ryan Brand; Nathaniel D Omans; Alicia Alonso; Caroline Sheridan; Marisa Mariani; Xiaoguang Dai; Eoghan Harrington; Alessandro Pastore; Juan R Cubillos-Ruiz; Wayne Tam; Ronald Hoffman; Raul Rabadan; Joseph M Scandura; Omar Abdel-Wahab; Peter Smibert; Dan A Landau
Journal:  Nature       Date:  2019-07-03       Impact factor: 49.962

9.  Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow.

Authors:  Leo Hansmann; Arnold Han; Livius Penter; Michaela Liedtke; Mark M Davis
Journal:  Cancer Immunol Res       Date:  2017-08-02       Impact factor: 11.151

10.  Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.

Authors:  Daniel J Hodson; Arthur L Shaffer; Wenming Xiao; George W Wright; Roland Schmitz; James D Phelan; Yandan Yang; Daniel E Webster; Lixin Rui; Holger Kohlhammer; Masao Nakagawa; Thomas A Waldmann; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-18       Impact factor: 11.205

View more
  4 in total

Review 1.  Understanding CLL biology through mouse models of human genetics.

Authors:  Elisa Ten Hacken; Catherine J Wu
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476

Review 2.  Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective.

Authors:  Marwan Kwok; Catherine J Wu
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

3.  Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.

Authors:  Ferran Nadeu; Romina Royo; Ramon Massoni-Badosa; Heribert Playa-Albinyana; Beatriz Garcia-Torre; Martí Duran-Ferrer; Kevin J Dawson; Marta Kulis; Ander Diaz-Navarro; Neus Villamor; Juan L Melero; Vicente Chapaprieta; Ana Dueso-Barroso; Julio Delgado; Riccardo Moia; Sara Ruiz-Gil; Domenica Marchese; Ariadna Giró; Núria Verdaguer-Dot; Mónica Romo; Guillem Clot; Maria Rozman; Gerard Frigola; Alfredo Rivas-Delgado; Tycho Baumann; Miguel Alcoceba; Marcos González; Fina Climent; Pau Abrisqueta; Josep Castellví; Francesc Bosch; Marta Aymerich; Anna Enjuanes; Sílvia Ruiz-Gaspà; Armando López-Guillermo; Pedro Jares; Sílvia Beà; Salvador Capella-Gutierrez; Josep Ll Gelpí; Núria López-Bigas; David Torrents; Peter J Campbell; Ivo Gut; Davide Rossi; Gianluca Gaidano; Xose S Puente; Pablo M Garcia-Roves; Dolors Colomer; Holger Heyn; Francesco Maura; José I Martín-Subero; Elías Campo
Journal:  Nat Med       Date:  2022-08-11       Impact factor: 87.241

Review 4.  Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell Dynamics.

Authors:  Livius Penter; Satyen H Gohil; Catherine J Wu
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.